Bern, Switzerland
Professor of Internal Medicine
University Hospital
Head, Clinical & Interventional Angiology
Swiss Cardiovascular Center
SCHEDULE FOR VEITHsymposium™
Tuesday, November 19, 2013
Session Moderator
SESSION-10: EMBOLIC AGENTS UTILIZED IN ENDOVASCULAR VASCULAR MALFORMATION
Presenter
SESSION 9: CLASSIFICATION AND IMAGING OF VASCULAR ANOMALIES
The Hamburg Classification For Vascular Malformations
7:20 AM - 7:30 AM
Presenter
SESSION 10: EMBOLIC AGENTS UTILIZED IN ENDOVASCULAR VASCULAR MALFORMATION
Sclerogel: A New Ethanol-Based Embolic Agent To Treat Low—Flow Vascular Malformations
9:00 AM - 9:10 AM
Presenter
SESSION 10: EMBOLIC AGENTS UTILIZED IN ENDOVASCULAR VASCULAR MALFORMATION
Ethanol: The Gold Standard For Embolization Of Extra-Truncular Vascular Malformations
9:10 AM - 9:20 AM
Panelist
SESSION 13: CHEST, ABDOMEN, AND PELVIS VASCULAR MALFORMATION MANAGEMENT
5:00 PM - 5:15 PM
Wednesday, November 20, 2013
Presenter
SESSION 30: LOWER EXTREMITY OCCLUSIVE DISEASE – HOT TOPICS II
Plain Old Balloon Angioplasty (POBA) Is Best For CLI For Infrapopliteal Disease: Do It Right And Don’t Replace It With Other Techniques Like DEBs Or DESs Which May Be Unsuitable And More Costly
8:42 AM - 8:47 AM
Thursday, November 21, 2013
Presenter
SESSION 45: NEW DEVELOPMENTS IN THE TREATMENT OF LOWER EXTREMITY ISCHEMIA, CLI, THE ANGIOSOME CONCEPT AND ACUTE LIMB ISCHEMIA
The Angiosome Concept Is Over-Rated: Collaterals Will Usually Heal The Foot If The Revascularization Is Effective
10:00 AM - 10:05 AM
 
previous next